{
  "id": "f029b3441de7a02a",
  "title": "Weekly Buzz : Intellia Gets FDA Nod For ATTRv - PN Trial ; Aprea APR - 1051 Paces ; CALC Halts KOURAGE",
  "description": "20260130T203000Z",
  "content": "",
  "source": "rttnews.com",
  "source_url": "https://www.rttnews.com/3615805/weekly-buzz-intellia-gets-fda-nod-for-attrv-pn-trial-aprea-s-apr-1051-paces-calc-halts-kourage.aspx",
  "published_at": "20260130T203000Z",
  "fetched_at": "2026-01-31T00:26:46.418942+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "fda",
    "intel"
  ],
  "location": "United States",
  "raw_data": {
    "url": "https://www.rttnews.com/3615805/weekly-buzz-intellia-gets-fda-nod-for-attrv-pn-trial-aprea-s-apr-1051-paces-calc-halts-kourage.aspx",
    "url_mobile": "https://www.rttnews.com/amp/3615805/weekly-buzz-intellia-gets-fda-nod-for-attrv-pn-trial-aprea-s-apr-1051-paces-calc-halts-kourage.aspx",
    "title": "Weekly Buzz : Intellia Gets FDA Nod For ATTRv - PN Trial ; Aprea APR - 1051 Paces ; CALC Halts KOURAGE",
    "seendate": "20260130T203000Z",
    "socialimage": "https://cdn.rttnews.com/articleimages/ustopstories/2025/december/fda-18122025-lt.jpg",
    "domain": "rttnews.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}